Long-term Outcome of Risankizumab in Crohn’s Disease: a Real-world GETAID Study
2024 · Clinical Gastroenterology and Hepatology · 20 citations
https://doi.org/10.1016/j.cgh.2024.04.016
B
Bénédicte Caron
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
108
Papers
1.1K
Citations
19
h-index
40
i10-index
Bénédicte Caron is an academic researcher from Inserm. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Eosinophilic Esophagitis. The author has an h-index of 19, co-authored 92 publications.
Papers by this author
worksEfficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
2022 · BMC Gastroenterology · 17 citations
https://doi.org/10.1186/s12876-022-02583-5
Defining Magnetic Resonance Imaging Treatment Response and Remission in Crohn’s Disease: A Systematic Review
2023 · Journal of Crohn s and Colitis · 17 citations
https://doi.org/10.1093/ecco-jcc/jjad125
An international multicentre study of <scp>SwiTching</scp> from Intravenous to subcutaneous <scp>inflixiMab</scp> and <scp>vEdolizumab</scp> in inflammatory bowel diseases: The <scp>TIME</scp> study
2024 · European Journal of Clinical Investigation · 10 citations
https://doi.org/10.1111/eci.14283
Comparative Effectiveness of Tofacitinib vs Upadacitinib for the Treatment of Acute Severe Ulcerative Colitis
2025 · Clinical Gastroenterology and Hepatology · 3 citations
https://doi.org/10.1016/j.cgh.2025.07.025
Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
2023 · BMC Gastroenterology · 0 citations
https://doi.org/10.1186/s12876-022-02636-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat